Peptinovo Biopharma
PrivateLast Round
Series A
Jan 20, 2026
Est. Valuation
$36.6M
Total Funding Raised
$18.56M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Peptinovo Biopharma is a biotechnology company that develops targeted nanomedicines using its proprietary PALM™ drug-delivery platform to enhance the efficacy of chemotherapy while reducing side effects.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptinovo Biopharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Peptinovo Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 20, 2026 | ||||
| Series A | Dec 16, 2024 | ||||
| SAFE | Jun 21, 2021 |
Peptinovo Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cantilever Opportunity Fund, LP | Series A, VC Round |
| Biosciences Research & Commercialization Center | SAFE |
| ID Ventures | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
$18M round led by Andreessen Horowitz.
- Dec 31, 2025
Partnered with Ardena Holding NV to achieve manufacturing stability.
Peptinovo Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Peptinovo Biopharma's valuation, stock price, and market status.